Teyi Pharmaceutical Group Co.,Ltd

SZSE:002728 Stock Report

Market Cap: CN¥4.6b

Teyi Pharmaceutical GroupLtd Future Growth

Future criteria checks 3/6

Teyi Pharmaceutical GroupLtd is forecast to grow earnings at 47.2% per annum. EPS is expected to grow by 48.4% per annum.

Key information

47.2%

Earnings growth rate

48.4%

EPS growth rate

Pharmaceuticals earnings growth18.9%
Revenue growth raten/a
Future return on equity17.7%
Analyst coverage

Low

Last updated20 May 2024

Recent future growth updates

No updates

Recent updates

We Think Teyi Pharmaceutical GroupLtd (SZSE:002728) Can Stay On Top Of Its Debt

Jun 06
We Think Teyi Pharmaceutical GroupLtd (SZSE:002728) Can Stay On Top Of Its Debt

Why Teyi Pharmaceutical GroupLtd's (SZSE:002728) Shaky Earnings Are Just The Beginning Of Its Problems

Apr 26
Why Teyi Pharmaceutical GroupLtd's (SZSE:002728) Shaky Earnings Are Just The Beginning Of Its Problems

Teyi Pharmaceutical Group Co.,Ltd's (SZSE:002728) Shares Bounce 29% But Its Business Still Trails The Market

Mar 06
Teyi Pharmaceutical Group Co.,Ltd's (SZSE:002728) Shares Bounce 29% But Its Business Still Trails The Market

Here's Why We Think Teyi Pharmaceutical GroupLtd (SZSE:002728) Is Well Worth Watching

Feb 27
Here's Why We Think Teyi Pharmaceutical GroupLtd (SZSE:002728) Is Well Worth Watching

Earnings and Revenue Growth Forecasts

SZSE:002728 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/202477871-1388N/A
6/30/2024843104-598N/A
3/31/202492815742132N/A
12/31/20231,067253113199N/A
9/30/20231,049269223317N/A
6/30/20231,040269267363N/A
3/31/2023996238282372N/A
12/31/2022887178281372N/A
9/30/2022816122136216N/A
6/30/2022785113107206N/A
3/31/202275813198207N/A
1/1/2022758127147257N/A
9/30/2021725118146258N/A
6/30/202169192130231N/A
3/31/202165263116213N/A
12/31/20206334480169N/A
9/30/20206686635143N/A
6/30/202074310863176N/A
3/31/2020852155105221N/A
12/31/201992117291222N/A
9/30/201993916851213N/A
6/30/201994917148217N/A
3/31/201992617144209N/A
12/31/201888515636188N/A
9/30/201882814669166N/A
6/30/2018777128N/A132N/A
3/31/2018739112N/A102N/A
12/31/2017687106N/A103N/A
9/30/2017689110N/A72N/A
6/30/2017680105N/A103N/A
3/31/201765094N/A154N/A
12/31/201665695N/A101N/A
9/30/201664885N/A145N/A
6/30/201663184N/A67N/A
3/31/201658480N/A7N/A
12/31/201551781N/A69N/A
9/30/201541978N/A23N/A
6/30/201535674N/A68N/A
3/31/201535578N/A59N/A
12/31/201434580N/A57N/A
9/30/201434782N/A97N/A
6/30/201434585N/AN/AN/A
3/31/201433782N/AN/AN/A
12/31/201334381N/A74N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 002728's forecast earnings growth (47.2% per year) is above the savings rate (2.8%).

Earnings vs Market: 002728's earnings (47.2% per year) are forecast to grow faster than the CN market (26.3% per year).

High Growth Earnings: 002728's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 002728's revenue is forecast to grow faster than the CN market.

High Growth Revenue: Insufficient data to determine if 002728's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 002728's Return on Equity is forecast to be low in 3 years time (17.7%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y